Advertisement

Typical Parkinson’s Disease Phenomenology

  • Steven J. FruchtEmail author
  • Pichet Termsarasab
Chapter
  • 36 Downloads

Abstract

The phenomenology of Parkinson’s disease was first described 7000 years ago and eloquently summarized 200 years ago by James Parkinson. Careful attention to the history and examination helps highlight the four cardinal features of Parkinson’s disease (tremor, rigidity, bradykinesia, and postural impairment), as well as alerting the clinician to the possibility of disorder mimicking Parkinson’s disease.

Keywords

Parkinson’s disease Tremor Rigidity Bradykinesia Postural impairment 

Supplementary material

Video 3.1

The videos of this chapter summarize the clinical phenomenology of idiopathic Parkinson’s disease (PD). The video is divided into seven segments: mild atremulous PD; tremor-predominant PD; cranial-predominant PD; young-onset hemi-PD; genetic forms of PD; advanced PD; and unusual phenomena in PD (MP4 3195422 kb)

References

  1. 1.
    Manyam BV. Paralysis agitans and levodopa in “Ayurveda”: ancient Indian medical treatise. Mov Disord. 1990;5(1):47–8.  https://doi.org/10.1002/mds.870050112.CrossRefPubMedGoogle Scholar
  2. 2.
    Damodaran M, Ramaswamy R. Isolation of l-3:4-dihydroxyphenylalanine from the seeds of Mucuna pruriens. Biochem J. 1937;31(12):2149–52.  https://doi.org/10.1042/bj0312149.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Zhang ZX, Dong ZH, Roman GC. Early descriptions of Parkinson disease in ancient China. Arch Neurol. 2006;63(5):782–4.  https://doi.org/10.1001/archneur.63.5.782.CrossRefPubMedGoogle Scholar
  4. 4.
    Koehler PJ, Keyser A. Tremor in Latin texts of Dutch physicians: 16th-18th centuries. Mov Disord. 1997;12(5):798–806.  https://doi.org/10.1002/mds.870120531.CrossRefPubMedGoogle Scholar
  5. 5.
    Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones; 1817.Google Scholar
  6. 6.
    Calne DB, Dubini A, Stern G. Did Leonardo describe Parkinson’s disease? N Engl J Med. 1989;320(9):594.  https://doi.org/10.1056/NEJM198903023200912.CrossRefPubMedGoogle Scholar
  7. 7.
    Keele KD. Leonardo da Vinci’s research on the central nervous system: essays on the history of Italian neurology. Proceedings of the International Symposium on the History of Neurology, Varenna, August 30–September 1, 1961. p. 15–30.Google Scholar
  8. 8.
    Goldman JG, Goetz CG. History of Parkinson’s disease. Handb Clin Neurol. 2007;83:107–28.  https://doi.org/10.1016/S0072-9752(07)83005-3.CrossRefPubMedGoogle Scholar
  9. 9.
    Currier RD. Did John Hunter give James Parkinson an idea? Arch Neurol. 1996;53(4):377–8.  https://doi.org/10.1001/archneur.1996.00550040117022.CrossRefPubMedGoogle Scholar
  10. 10.
    Sanders WR. Paralysis agitans. In: Reynolds JR, editor. System of medicine, vol. 2. Philadelphia: JB Lippincott; 1868. p. 184–204.Google Scholar
  11. 11.
    Louis ED. The shaking palsy, the first forty-five years: a journey through the British literature. Mov Disord. 1997;12(6):1068–72.  https://doi.org/10.1002/mds.870120638.CrossRefPubMedGoogle Scholar
  12. 12.
    Goetz CG. Charcot the clinician: the Tuesday lessons. New York: Raven Press; 1987.Google Scholar
  13. 13.
    Gowers WR. A manual of diseases of the nervous system, vol. II. London: J. & A. Churchill; 1886.Google Scholar
  14. 14.
    Charcot JM. Leçons du Mardi: Policlinique de la Salpêtrière, 1887–1888. Bureaux du Progrès Médical, Paris: Lesson of June 12, 1888.Google Scholar
  15. 15.
    Vilensky JA, editor. Encephalitis lethargica: during and after the epidemic. New York: Oxford University Press; 2011.Google Scholar
  16. 16.
    Hoffman LA, Vilensky JA. Encephalitis lethargica: 100 years after the epidemic. Brain. 2017;140(8):2246–51.  https://doi.org/10.1093/brain/awx177.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    von Economo C. Die Encephalitis lethargica, ihre Nachkrankheiten und ihre Behardlung. Berlin: Urban and Schwarzenberg. (Published in English in 1931:Translated by K. O. Newman; London: Oxford University Press.).; 1929.Google Scholar
  18. 18.
    Denny-Brown D. The basal ganglia and their relation to disorders of movement. London: Oxford University Press; 1962.Google Scholar
  19. 19.
    Fearnley JM, Lees AJ. Ageing and Parkinson’s disease: substantia nigra regional selectivity. Brain. 1991;114(Pt 5):2283–301.  https://doi.org/10.1093/brain/114.5.2283.CrossRefPubMedGoogle Scholar
  20. 20.
    O’Keeffe FM, Murray B, Coen RF, Dockree PM, Bellgrove MA, Garavan H, et al. Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy. Brain. 2007;130(Pt 3):753–64.  https://doi.org/10.1093/brain/awl367.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Ha AD, Jankovic J. Pain in Parkinson’s disease. Mov Disord. 2012;27(4):485–91.  https://doi.org/10.1002/mds.23959.CrossRefPubMedGoogle Scholar
  22. 22.
    Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1999;67(5):646–50.  https://doi.org/10.1136/jnnp.67.5.646.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Thenganatt MA, Louis ED. Distinguishing essential tremor from Parkinson’s disease: bedside tests and laboratory evaluations. Expert Rev Neurother. 2012;12(6):687–96.  https://doi.org/10.1586/ern.12.49.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Chang MH, Chang TW, Lai PH, Sy CG. Resting tremor only: a variant of Parkinson’s disease or of essential tremor. J Neurol Sci. 1995;130(2):215–9.  https://doi.org/10.1016/0022-510x(95)00033-x.CrossRefPubMedGoogle Scholar
  25. 25.
    Marek K, Jennings D, Seibyl J. Imaging the dopamine system to assess disease-modifying drugs: studies comparing dopamine agonists and levodopa. Neurology. 2003;61(6 Suppl 3):S43–8.  https://doi.org/10.1212/wnl.61.6_suppl_3.s43.CrossRefPubMedGoogle Scholar
  26. 26.
    Erro R, Schneider SA, Stamelou M, Quinn NP, Bhatia KP. What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies. J Neurol Neurosurg Psychiatry. 2016;87(3):319–23.  https://doi.org/10.1136/jnnp-2014-310256.CrossRefPubMedGoogle Scholar
  27. 27.
    Marek K, Seibyl J, Eberly S, Oakes D, Shoulson I, Lang AE, et al. Longitudinal follow-up of SWEDD subjects in the PRECEPT Study. Neurology. 2014;82(20):1791–7.  https://doi.org/10.1212/WNL.0000000000000424.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Doherty KM, van de Warrenburg BP, Peralta MC, Silveira-Moriyama L, Azulay JP, Gershanik OS, et al. Postural deformities in Parkinson’s disease. Lancet Neurol. 2011;10(6):538–49.  https://doi.org/10.1016/S1474-4422(11)70067-9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Movement DisordersNew York University Grossman School of Medicine, The Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders, NYU Langone HealthNew YorkUSA
  2. 2.Division of Neurology, Faculty of MedicineRamathibodi Hospital, Mahidol UniversityBangkokThailand

Personalised recommendations